Genertec Universal Medical Group Company Limited
2666.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$9.18B
Close$
$6.79
47.8% upside
Current Fair Value
47.8% upsideUndervalued by 47.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $9.18 Billion |
|---|---|
| Enterprise Value | $37.86 Billion |
| Dividend Yield | $0.36 (7.89%) |
| Earnings per Share | $1.08 |
| Beta | 0.58 |
| Outstanding Shares | 2,014,204,924 |
Return
| Return on Equity | 21.13% |
|---|---|
| Return on Assets | 4.81% |
| Return on Invested Capital | 54.66% |
Valuation & Multiples
| P/E Ratio | 3.63 |
|---|---|
| PEG | 49.71 |
| Price to Sales | 0.38 |
| Price to Book Ratio | 0.42 |
| Enterprise Value to Revenue | 1.46 |
| Enterprise Value to EBIT | 0.82 |
| Enterprise Value to Net Income | 9 |
| Total Debt to Enterprise | 0.81 |
| Debt to Equity | 1.61 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 26, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
March 31, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Genertec Universal Medical Group Company Limited
23,266 employees
CEO: Qi Xia Genertec Universal Medical Group Company Limited, founded in 1984 and based in Beijing, China, provides extensive financing and advisory services across the People's Republic of China, alongside operating a significant healthcare busines...